- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: bevacizumab erlotinib hydrochloride
Total 10071 results
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Second Affiliated Hospital...Unknown
-
Mayo ClinicGenentech, Inc.CompletedCholangiocarcinoma | Primary Sclerosing Cholangitis | Chemoprevention | Trisomy 7United States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Genentech, Inc.; Schering-PloughWithdrawnLung Cancer | Metastatic Cancer
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung Cancer | Malignant Solid TumorUnited States
-
Sun Yat-sen UniversityTerminatedNon-Small Cell Lung CarcinomaChina
-
Memorial Sloan Kettering Cancer CenterCompletedOligometastatic Lung AdenocarcinomaUnited States
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSerbia
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Spain, Russian Federation, France, Bulgaria, Germany, Estonia, Italy, Poland, Taiwan, United Kingdom, Singapore, Ireland, Belgium
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerAustralia, China, Korea, Republic of, Denmark, Germany, Greece, Russian Federation, Hungary, France, Netherlands, New Zealand, Spain, Austria, Slovakia, United Kingdom, Malaysia, Belgium, Lithuania, South Africa, Slovenia, Italy, ... and more
-
Genentech, Inc.CompletedLung Cancer | Non-small-cell Lung CarcinomaUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | Papillary Serous Mullerian Tumor | Clear Cell Mullerian TumorUnited States
-
M.D. Anderson Cancer CenterCompleted
-
NYU Langone HealthOSI PharmaceuticalsTerminated
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Masonic Cancer Center, University of MinnesotaWithdrawnCervical CancerUnited States
-
University of CincinnatiGenentech, Inc.WithdrawnMyelodysplastic SyndromeUnited States
-
Dana-Farber Cancer InstituteAstellas Pharma IncTerminatedNon-Small Cell Lung Cancer | Epidermal Growth Factor ReceptorUnited States
-
Eli Lilly and CompanyCompletedCarcinoma, Non-Small-Cell LungUnited States, Germany, Spain, Belgium, France, United Kingdom, Netherlands, Italy, Israel, Korea, Republic of
-
Dartmouth-Hitchcock Medical CenterSanofi; Genentech, Inc.CompletedCarcinoma, Non-Small-Cell Lung | NSCLC | Non-small Cell Lung CancerUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.CompletedNon-small Cell Lung CancerUnited States
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerPortugal
-
Oncology Specialists, S.C.CompletedProstate CancerUnited States
-
Groupe Francophone des MyelodysplasiesRoche Pharma AGCompleted
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSpain, Taiwan, Japan, United States, France, Germany, Korea, Republic of, Malaysia
-
University of UtahCompleted
-
Wu Jieping Medical FoundationZhejiang Cancer Hospital; Fudan University; Shanghai Chest Hospital; Shanghai Pulmonary... and other collaboratorsUnknownNon Small Cell Lung Cancer, OligometastaticChina
-
Ontario Clinical Oncology Group (OCOG)Roche Pharma AGCompletedNon-small Cell Lung CancerCanada
-
Zhejiang Cancer HospitalUnknownNon-small Cell Lung CancerChina
-
Amsterdam UMC, location VUmcCompletedNon-Small Cell Lung Cancer | Brain MetastasesNetherlands
-
Guangdong Provincial People's HospitalUnknownNon-Small Cell Lung Cancer | Brain Metastases
-
Hospital of NavarraDr. Enrique Martínez LópezUnknownCarcinoma, Non-Small-Cell LungSpain
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Hospital Arnau de VilanovaUnknown
-
National Cancer Institute (NCI)TerminatedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Eisai Inc.CompletedNon-small Cell Lung CancerUnited States, Hong Kong, Taiwan, Korea, Republic of, Singapore, Thailand, Malaysia
-
National Cancer Center, KoreaHoffmann-La RocheActive, not recruitingNSCLC Stage II | NSCLC, Stage IIIAKorea, Republic of
-
David M. Jackman, MDBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's HospitalCompletedNon-small Cell Lung CancerUnited States
-
PfizerCompletedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Brazil, Spain, United Kingdom, Singapore, Canada, Hong Kong, Poland, Puerto Rico
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerSpain, France, Germany, Switzerland, China, Turkey, Denmark, Egypt, Netherlands
-
University of Alabama at BirminghamGenentech, Inc.; OSI PharmaceuticalsCompletedHead and Neck CancerUnited States
-
The First Affiliated Hospital of Guangzhou Medical...Unknown
-
University Hospital, Strasbourg, FranceUnknownChronic Hepatitis C Infection | HCV Genotype 1bFrance
-
Samsung Medical CenterUnknown
-
Henry Ford Health SystemGenentech, Inc.TerminatedHead and Neck Cancer | Carcinoma, Squamous Cell
-
Anhui Medical UniversityUnknownSelf Efficacy | Drug ToxicityChina
-
Eli Lilly and CompanyActive, not recruitingMetastatic Non-Small Cell Lung CancerFrance, Spain, United States, Italy, Canada, Taiwan, Hong Kong, Japan, Turkey, Korea, Republic of, United Kingdom, Germany, Romania, Greece
-
Heather WakeleeNovartis; Genentech, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC), Recurrent | Non-small Cell Lung Cancer (NSCLC), Stage IVUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Northwestern University; Dana-Farber Cancer Institute and other collaboratorsCompletedBronchioloalveolar Cell Variant of Non-small Cell Lung CancerUnited States
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerSerbia